T1	Participants 196 310	gonadotropin-releasing hormone agonist (GnRH-a) in ovulation induction in an in vitro fertilization (IVF) program.
T2	Participants 454 520	Forty-eight patients having IVF for the first time were randomized
T3	Participants 948 972	patients undergoing IVF.
